Market Tracker

05/27 6:05am ET

Neogenomics Inc (NASDAQ:NEO)

8.66
Delayed Data
As of May 26
 +0.015 / +0.17%
Today’s Change
5.05
Today|||52-Week Range
8.99
+10.10%
Year-to-Date

Today’s Trading

Previous close8.65
Today’s open8.65
Day’s range8.62 - 8.76
Volume363,228
Average volume (3 months)352,085
Market cap$667.1M
Dividend yield--
Data as of 05/26/2016

Growth & Valuation

Earnings growth (last year)-300.00%
Earnings growth (this year)+104.76%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.62%
P/E ratioNM
Price/Sales4.77
Price/Book3.13

Competitors

 Today’s
change
Today’s
% change
GNMKGenMark Diagnostics ...+0.03+0.42%
NVTAInvitae Corp+0.21+2.28%
PTIProteostasis Therape...+1.04+7.24%
RDNTRadNet Inc-0.14-2.65%
Data as of 05/26/2016

Financials

Next reporting dateJuly 14, 2016
EPS forecast (this quarter)$0.03
Annual revenue (last year)$99.8M
Annual profit (last year)-$2.5M
Net profit margin-2.54%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Chief Operating Officer
Robert J. Shovlin
Corporate headquarters
Fort Myers, Florida

Forecasts